COMBINED PRESENCE OF THREE MGMT GENE-POLYMORPHISMS IN A GLIOBLASTOMA PATIENT, WHO DEVELOPED SEVERE MYELOSUPPRESSION FOLLOWING TEMOZOLOMIDE CHEMOTHERAPY

Abstract

12th Meeting of the European-Association-of-Neuro-Oncology, GERMANY, OCT 12-16, 2016